Faron to Present at Oppenheimer Conference
Faron Pharmaceuticals Oy (“Faron” or the “Company”) Faron Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference TURKU – FINLAND, March 11, 2021 – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON) , the clinical stage biopharmaceutical company, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron Pharmaceuticals, will present at the virtual Oppenheimer 31st Annual Healthcare Conference on Thursday, March 18, 2021 at 10:40 a.m. ET. An audio webcast of the presentation will be available in the "Investors" section on Faron'